Bob Smith

Pharmaceutical Leader

Bio

Bob Smith has worked for over a decade bringing life-changing therapies to scleroderma patients with pulmonary arterial hypertension (PAH). He has experienced scleroderma with friends and joined the Board of Directors in 2019.

go back

You have selected a link to a website that exists outside of the srfcure.org website. The Scleroderma Research Foundation provides access to these sites as a service to srfcure.org visitors and is not responsible or liable for the content and information presented within any non- Scleroderma Research Foundation external site. Following a link to an external page is at at your own risk.

To learn more about the 23andMe Systemic Sclerosis Research Study and enroll: Continue to 23andMe …

Continue to Survey …